Clinical study with a sialagogue drug (sulfarlem S 25 = TTPT) in the treatment of xerostomia
Häusler, R.; Ritschard, J.
Schweizerische Rundschau für Medizin Praxis 68(33): 1063-1068
1979
ISSN/ISBN: 1013-2058 PMID: 471936 Document Number: 145384
Document emailed within 1 workday
Related Documents
Cogliandro, A. 1982: Clinical study of a drug combination in the treatment of metarheumatic and metatraumatic disorders La Clinica Terapeutica 101(3): 267-274Lachard, J.; Jars, G.; Fourestier, J. 1975: Clinical study of a new drug: Imudon, in the treatment of diseases of the oral mucosa and periodontium Semaine des Hopitaux. Therapeutique 51(3): 177-182
Volanschi, D.; Pintilie, C. 1978: Combined treatment of epileptics with phenobarbital and diphenylhydantoin in small doses versus separate treatment with large doses of either drug. a study of the clinical effects Neurologie et Psychiatrie 16(4): 259-269
Sári, K.; Dombi, C.; Czeglédy, A.; Bánóczy, J. 1994: Treatment of xerostomia with lactoperoxidase-containing mouthwashes and toothpaste Fogorvosi Szemle 87(9): 263-272
Katsambas, A.; Vareltzidis, A. 1973: Therapeutic action of a new non-steroid drug (bufexamac) in the treatment of inflammatory dermatologic diseases. Double-blind clinical study Bruxelles Medical 53(8): 463-468
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Lewisham, K.M.; Ferguson, M.M.; Rades, T. 2001: Emulsions as oral moisturisers for the treatment of severe xerostomia Die Pharmazie 56(7): 591-592
Sugano, S.; Takeyama, I.; Ogino, S.; Kenmochi, M.; Kaneko, T. 1996: Effectiveness of formula ophiopogoins in the treatment of xerostomia and pharyngoxerosis Acta Oto-Laryngologica. Supplementum 522: 124-129
Khovidhunkit, S.-o.P.; Suwantuntula, T.; Thaweboon, S.; Mitrirattanakul, S.; Chomkhakhai, U.; Khovidhunkit, W. 2009: Xerostomia, hyposalivation, and oral microbiota in type 2 diabetic patients: a preliminary study Journal of the Medical Association of Thailand 92(9): 1220-1228
Fife, R.S.; Chase, W.F.; Dore, R.K.; Wiesenhutter, C.W.; Lockhart, P.B.; Tindall, E.; Suen, J.Y. 2002: Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial Archives of Internal Medicine 162(11): 1293-1300
Gianzi, F.P.; Salamina, G.; Binkin, N.; Lattanzi, A.; Rezza, G. 1993: Study on attitudes and practices of directors of drug addiction treatment centers regarding HIV infection prevention in drug addicts Annali di Igiene: Medicina Preventiva e di Comunita 5(4): 241-245
Sangthawan, D.; Watthanaarpornchai, S.; Phungrassami, T. 2001: Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia Journal of the Medical Association of Thailand 84(2): 195-203
Etheridge, R.M.; Craddock, S.G.; Wechsberg, W.M. 1995: Counseling and services for HIV infection, AIDS and AIDS-risk behaviors in drug abuse treatment Findings from the NIDA drug abuse treatment outcome study PHILADELPHIA SCIENCES GROUP HIV infection in women: Setting a new agenda : P99
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Christiani, K.; Möller, W.D. 1973: Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor Münchener Medizinische Wochenschrift 115(16): 711-713
Chitapanarux, I.; Kamnerdsupaphon, P.; Tharavichitkul, E.; Sumitsawan, Y.; Sittitrai, P.; Pattarasakulchai, T.; Lorvidhaya, V.; Sukthomya, V.; Pukanhaphan, N.; Traisatit, P. 2008: Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial Journal of the Medical Association of Thailand 91(9): 1410-1415
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
True, A.C. 1964: The Current Clinical Drug Study Journal of the Medical Society of New Jersey 61: 405-409
Reetz-Kokott, U.; Müller-Oerlinghausen, B. 1996: Has drug treatment of manic disorders changed in clinical routine practice? Retrospective analysis of treatment modalities and results in a university psychiatric clinic Der Nervenarzt 67(3): 229-234